PLAT and ischemic stroke: The authors showed that patients receiving intravenous tissue plasminogen activator (IV-tPA) had an increased risk of recurrent ischemic stroke in the first 24 h compared to those who did not receive IV-tPA (hazard risk, HR 14.79; 95% CI 3.41–64.25, p < 0.0001).